Progression and metastasis in a transgenic mouse breast cancer model: Effects of exposure to in vivo hypoxia

Cancer Letters

Volumn 282, Issue 1, 2009, Pages 98-108

  Kalliomäki, Tuula M ^a,b   McCallum, Gordon ^c   Wells, Peter G ^c   Hill, Richard P ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Genomic instability; Hypoxia; Macrophages; Metastasis; MMTV Neu

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; REDOX EFFECTOR FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; HYPOXIA; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE;

ACUTE DISEASE; ANIMALS; ANOXIA; BREAST NEOPLASMS; CELL HYPOXIA; CHRONIC DISEASE; DEOXYGUANOSINE; DISEASE PROGRESSION; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; RECEPTOR, ERBB-2;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 67649413123     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.009     Document Type: Article

References (64)

1. Cardenas-Navia L.I., Mace D., Richardson R.A., Wilson D.F., Shan S., and Dewhirst M.W. The pervasive presence of fluctuating oxygenation in tumors. Cancer Res. 68 (2008) 5812-5819
2. Brurberg K.G., Gaustad J.V., Mollatt C.S., and Rofstad E.K. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia 10 (2008) 727-735
3. Lanzen J., Braun R.D., Klitzman B., Brizel D., Secomb T.W., and Dewhirst M.W. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res. 66 (2006) 2219-2223
4. Brown J.M. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today 6 (2000) 157-162
5. Subarsky P., and Hill R.P. The hypoxic tumour microenvironment and metastatic progression. Clin. Exp. Metastas. 20 (2003) 237-250
6. Milosevic M., Fyles A., Hedley D., and Hill R. The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. Semin. Radiat. Oncol. 14 (2004) 249-258
7. Måseide K., Kalliomäki T., Hill R.P., and Meadows G.G.E. Microenvironmental effects on tumour progression and metastasis. Integration/Interaction of Oncologic Growth Series: Cancer Growth and Progression 15 (2005) 1-29
8. Chaudary N., and Hill R.P. Hypoxia and metastasis in breast cancer. Breast Dis. 26 (2006) 55-64
9. Reynolds T.Y., Rockwell S., and Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56 (1996) 5754-5757
10. Rofstad E.K., Johnsen N.M., and Lyng H. Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro. Br. J. Cancer 27 Suppl. (1996) S136-S139
11. Young S.D., Marshall R.S., and Hill R.P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85 (1988) 9533-9537
12. Coquelle A., Toledo F., Stern S., Bieth A., and Debatisse M. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2 (1998) 259-265
13. Shahrzad S., Shirasawa S., Sasazuki T., Rak J.W., and Coomber B.L. Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. Oncogene 27 (2008) 3729-3738
14. Huang L.E., Bindra R.S., Glazer P.M., and Harris A.L. Hypoxia-induced genetic instability - a calculated mechanism underlying tumor progression. J. Mol. Med. 85 (2007) 139-148
15. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
16. Sieber O., Heinimann K., and Tomlinson I. Genomic stability and tumorigenesis. Semin. Cancer Biol. 15 (2005) 61-66
17. Loeb L.A., Loeb K.R., and Anderson J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci. USA 100 (2003) 776-781
18. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., and Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
19. Zhang L., and Hill R.P. Hypoxia enhances metastatic efficiency by up regulating mdm2 in KHT cells and increasing resistance to apoptosis. Cancer Res. 54 (2004) 4180-4189
20. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282 (2002) C227-C241
21. Brown N.S., and Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3 (2001) 323-327 Epub 2001 Jul 23
22. Benz C.C., and Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat. Rev. Cancer 8 (2008) 875-879
23. Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 8 (2008) 180-192
24. Sacco M.G., Soldati S., Indraccolo S., Cato E.M., Cattaneo L., Scanziani E., and Vezzoni P. Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer. Gene Ther. 10 (2003) 1903-1909
25. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., and Muller W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89 (1992) 10578-10582
26. I.L. Andrulis, S.B. Bull, M.E. Blackstein, D. Sutherland, C. Mak, S. Sidlofsky, K.P. Pritzker, R.W. Hartwick, W. Hanna, L. Lickley, R. Wilkinson, A. Qizilbash, U. Ambus, M. Lipa, H. Weizel, A. Katz, M. Baida, S. Mariz, G. Stoik, P. Dacamara, D. Strongitharm, W. Geddie, D. McCready, neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer, Toronto Breast Cancer Study Group, J. Clin. Oncol. 16 (1998) 1340-1349.
27. Giatromanolaki A., Koukourakis M.I., Simopoulos C., Polychronidis A., Gatter K.C., Harris A.L., and Sivridis E. c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin. Cancer Res. 10 (2004) 7972-7977
28. Siegel P.M., Dankort D.L., Hardy W.R., and Muller W.J. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell Biol. 14 (1994) 7068-7077
29. Chan R., Muller W.J., and Siegel P.M. Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors. Ann. NY Acad. Sci. 889 (1999) 45-51
30. De Schutter H., Barbe B., Spaepen M., Begg A.C., Balm A., Gregoire V., Haustermans K., Mahy P., Vander Poorten V., and Nuyts S. Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. Radiother. Oncol. 80 (2006) 143-150
31. Cairns R.A., Kalliomaki T., and Hill R.P. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 61 (2001) 8903-8908
32. Shyamala G., Yang X., Silberstein G., Barcellos-Hoff M.H., and Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc. Natl. Acad. Sci. USA 95 (1998) 696-701
33. Aarstad H.J., and Seljelid R. Effects of stress on the growth of a fibrosarcoma in nu/nu and conventional mice. Scand. J. Immunol. 35 (1992) 209-215
34. Moynihan J.A., Brenner G.J., Ader R., and Cohen N. The effects of handling adult mice on immunologically relevant processes. Ann. NY Acad. Sci. 650 (1992) 262-267
35. Ravanat J.L., Douki T., Duez P., Gremaud E., Herbert K., Hofer T., Lasserre L., Saint-Pierre C., Favier A., and Cadet J. Cellular background level of 8-oxo-7,8-dihydro-2′-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis 23 (2002) 1911-1918
36. Kalliomaki T.M., McCallum G., Lunt S.J., Wells P.G., and Hill R.P. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer 8 (2008) 151
37. David S.S., O'Shea V.L., and Kundu S. Base-excision repair of oxidative DNA damage. Nature 447 (2007) 941-950
38. Evans A.R., Limp-Foster M., and Kelley M.R. Going APE over ref-1. Mutat. Res. 461 (2000) 83-108
39. Murdoch C., and Lewis C.E. Macrophage migration and gene expression in response to tumor hypoxia. Int. J. Cancer 117 (2005) 701-708
40. Tsutsui S., Yasuda K., Suzuki K., Tahara K., Higashi H., and Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol. Rep. 14 (2005) 425-431
41. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., Qian H., Xue X.N., and Pollard J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66 (2006) 11238-11246
42. Allavena P., Sica A., Solinas G., Porta C., and Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66 (2008) 1-9
43. Murdoch C., Giannoudis A., and Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104 (2004) 2224-2234
44. Vujaskovic Z., Rosen E.L., Blackwell K.L., Jones E.L., Brizel D.M., Prosnitz L.R., Samulski T.V., and Dewhirst M.W. Ultrasound guided pO(2) measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int. J. Hyperthermia 19 (2003) 498-506
45. Liu S., Liu W., Jakubczak J.L., Erexson G.L., Tindall K.R., Chan R., Muller W.J., Adhya S., Garges S., and Merlino G. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 3770-3775
46. Jefford C.E., and Irminger-Finger I. Mechanisms of chromosome instability in cancers. Crit. Rev. Oncol. Hematol. 59 (2006) 1-14
47. Malins D.C., Polissar N.L., Ostrander G.K., and Vinson M.A. Single 8-oxo-guanine and 8-oxo-adenine lesions induce marked changes in the backbone structure of a 25-base DNA strand. Proc. Natl. Acad. Sci. USA 97 (2000) 12442-12445
48. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., and Huang P. Redox regulation of cell survival. Antioxid. Redox. Signal 10 (2008) 1343-1374
49. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 401 (2007) 1-11
50. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 387 (1997) 147-163
51. Cadet J., Douki T., Gasparutto D., and Ravanat J.L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 531 (2003) 5-23
52. Klungland A., and Bjelland S. Oxidative damage to purines in DNA: role of mammalian Ogg1. DNA Repair (Amst) 6 (2007) 481-488
53. Nagashima M., Tsuda H., Takenoshita S., Nagamachi Y., Hirohashi S., Yokota J., and Kasai H. 8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett. 90 (1995) 157-162
54. Charles M.J., Schell M.J., Willman E., Gross H.B., Lin Y., Sonnenberg S., and Graham M.L. Organochlorines and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in cancerous and noncancerous breast tissue: do the data support the hypothesis that oxidative DNA damage caused by organochlorines affects breast cancer?. Arch. Environ. Contam. Toxicol. 41 (2001) 386-395
55. Papp-Szabo E., Josephy P.D., and Coomber B.L. Microenvironmental influences on mutagenesis in mammary epithelial cells. Int. J. Cancer 116 (2005) 679-685
56. Diakowska D., Krzystek-Korpacka M., Lewandowski A., Grabowski K., and Diakowski W. Evaluation of 8-hydroxydeoxyguanosine, thiobarbituric acid-reactive substances and total antioxidant status as possible disease markers in oesophageal malignancies. Clin. Biochem. 41 (2008) 796-803
57. Miyake H., Hara I., Kamidono S., and Eto H. Prognostic significance of oxidative DNA damage evaluated by 8-hydroxy-2′-deoxyguanosine in patients undergoing radical nephrectomy for renal cell carcinoma. Urology 64 (2004) 1057-1061
58. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., and Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38 (2006) 1043-1048
59. Ellsworth R.E., Hooke J.A., Love B., Kane J.L., Patney H.L., Ellsworth D.L., and Shriver C.D. Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors. Breast Cancer Res. Treat. (2007)
60. Lin E.Y., Nguyen A.V., Russell R.G., and Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193 (2001) 727-740
61. Lamagna C., Aurrand-Lions M., and Imhof B.A. Dual role of macrophages in tumor growth and angiogenesis. J. Leukoc. Biol. (2006)
62. Bingle L., Brown N.J., and Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196 (2002) 254-265
63. Crowther M., Brown N.J., Bishop E.T., and Lewis C.E. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70 (2001) 478-490
64. Leo C., Giaccia A.J., and Denko N.C. The hypoxic tumor microenvironment and gene expression. Semin. Radiat. Oncol. 14 (2004) 207-214